Exact Mass: 445.1899
Exact Mass Matches: 445.1899
Found 258 metabolites which its exact mass value is equals to given mass value 445.1899
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
tridihexethyl iodide
C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent
cerdulatinib
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
Tak-593
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor > C93259 - VEGFR Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163953 - VEGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
N-Oxide abiraterone sulfate
N-Oxide abiraterone sulfate is a metabolite of abiraterone. Abiraterone is a drug used in castration-resistant prostate cancer (formerly hormone-resistant or hormone-refractory prostate cancer) (prostate cancer not responding to androgen deprivation or treatment with antiandrogens). It is formulated as the prodrug abiraterone acetate and marketed under the trade name Zytiga. After an expedited six-month review, abiraterone was approved by the U.S. Food and Drug Administration (FDA) in April 2011. (Wikipedia)
P-Hydroxyhippuryl-his-leu-OH
N-(4-Fluorobenzyl)-3-oxo-1,1-diphenyltetrahydro-1H-oxazolo[3,4-a]pyrazine-7(3H)-carboxamide
Ala Met Pro Gln
Ala Met Gln Pro
Ala Asn Asn Gln
Ala Asn Gln Asn
Ala Pro Met Gln
Ala Pro Gln Met
Ala Gln Met Pro
Ala Gln Asn Asn
Ala Gln Pro Met
Cys Ile Asn Pro
Cys Ile Pro Asn
Cys Leu Asn Pro
Cys Leu Pro Asn
Cys Asn Ile Pro
Cys Asn Leu Pro
Cys Asn Pro Ile
Cys Asn Pro Leu
Cys Pro Ile Asn
Cys Pro Leu Asn
Cys Pro Asn Ile
Cys Pro Asn Leu
Cys Pro Gln Val
Cys Pro Val Gln
Cys Gln Pro Val
Cys Gln Val Pro
Cys Val Pro Gln
Cys Val Gln Pro
Asp Asn Pro Thr
Asp Asn Thr Pro
Asp Pro Asn Thr
Asp Pro Gln Ser
Asp Pro Ser Gln
Asp Pro Thr Asn
Asp Gln Pro Ser
Asp Gln Ser Pro
Asp Ser Pro Gln
Asp Ser Gln Pro
Asp Thr Asn Pro
Asp Thr Pro Asn
Glu Asn Pro Ser
Glu Asn Ser Pro
Glu Pro Asn Ser
Glu Pro Ser Asn
Glu Ser Asn Pro
Glu Ser Pro Asn
Gly Asn Gln Gln
Gly Pro Ser Trp
Gly Pro Trp Ser
Gly Gln Asn Gln
Gly Gln Gln Asn
Gly Ser Pro Trp
Gly Ser Trp Pro
Gly Trp Pro Ser
Gly Trp Ser Pro
Ile Cys Asn Pro
Ile Cys Pro Asn
Ile Asn Cys Pro
Ile Asn Pro Cys
Ile Pro Cys Asn
Ile Pro Asn Cys
Leu Cys Asn Pro
Leu Cys Pro Asn
Leu Asn Cys Pro
Leu Asn Pro Cys
Leu Pro Cys Asn
Leu Pro Asn Cys
Met Ala Pro Gln
Met Ala Gln Pro
Met Pro Ala Gln
Met Pro Gln Ala
Met Gln Ala Pro
Met Gln Pro Ala
Asn Ala Asn Gln
Asn Ala Gln Asn
Asn Cys Ile Pro
Asn Cys Leu Pro
Asn Cys Pro Ile
Asn Cys Pro Leu
Asn Asp Pro Thr
Asn Asp Thr Pro
Asn Glu Pro Ser
Asn Glu Ser Pro
Asn Gly Gln Gln
Asn Ile Cys Pro
Asn Ile Pro Cys
Asn Leu Cys Pro
Asn Leu Pro Cys
Asn Asn Ala Gln
Asn Asn Gln Ala
Asn Pro Cys Ile
Asn Pro Cys Leu
Asn Pro Asp Thr
Asn Pro Glu Ser
Asn Pro Ile Cys
Asn Pro Leu Cys
Asn Pro Ser Glu
Asn Pro Thr Asp
Asn Gln Ala Asn
Asn Gln Gly Gln
Asn Gln Asn Ala
Asn Gln Gln Gly
Asn Ser Glu Pro
Asn Ser Pro Glu
Asn Thr Asp Pro
Asn Thr Pro Asp
Pro Ala Met Gln
Pro Ala Gln Met
Pro Cys Ile Asn
Pro Cys Leu Asn
Pro Cys Asn Ile
Pro Cys Asn Leu
Pro Cys Gln Val
Pro Cys Val Gln
Pro Asp Asn Thr
Pro Asp Gln Ser
Pro Asp Ser Gln
Pro Asp Thr Asn
Pro Glu Asn Ser
Pro Glu Ser Asn
Pro Gly Ser Trp
Pro Gly Trp Ser
Pro Ile Cys Asn
Pro Ile Asn Cys
Pro Leu Cys Asn
Pro Leu Asn Cys
Pro Met Ala Gln
Pro Met Gln Ala
Pro Asn Cys Ile
Pro Asn Cys Leu
Pro Asn Asp Thr
Pro Asn Glu Ser
Pro Asn Ile Cys
Pro Asn Leu Cys
Pro Asn Ser Glu
Pro Asn Thr Asp
Pro Gln Ala Met
Pro Gln Cys Val
Pro Gln Asp Ser
Pro Gln Met Ala
Pro Gln Ser Asp
Pro Gln Val Cys
Pro Ser Asp Gln
Pro Ser Glu Asn
Pro Ser Gly Trp
Pro Ser Asn Glu
Pro Ser Gln Asp
Pro Ser Trp Gly
Pro Thr Asp Asn
Pro Thr Asn Asp
Pro Val Cys Gln
Pro Val Gln Cys
Pro Trp Gly Ser
Pro Trp Ser Gly
Gln Ala Met Pro
Gln Ala Asn Asn
Gln Ala Pro Met
Gln Cys Pro Val
Gln Cys Val Pro
Gln Asp Pro Ser
Gln Asp Ser Pro
Gln Gly Asn Gln
Gln Gly Gln Asn
Gln Met Ala Pro
Gln Met Pro Ala
Gln Asn Ala Asn
Gln Asn Gly Gln
Gln Asn Asn Ala
Gln Asn Gln Gly
Gln Pro Ala Met
Gln Pro Cys Val
Gln Pro Asp Ser
Gln Pro Met Ala
Gln Pro Ser Asp
Gln Pro Val Cys
Gln Gln Gly Asn
Gln Gln Asn Gly
Gln Ser Asp Pro
Gln Ser Pro Asp
Gln Val Cys Pro
Gln Val Pro Cys
Ser Asp Pro Gln
Ser Asp Gln Pro
Ser Glu Asn Pro
Ser Glu Pro Asn
Ser Gly Pro Trp
Ser Gly Trp Pro
Ser Asn Glu Pro
Ser Asn Pro Glu
Ser Pro Asp Gln
Ser Pro Glu Asn
Ser Pro Gly Trp
Ser Pro Asn Glu
Ser Pro Gln Asp
Ser Pro Trp Gly
Ser Gln Asp Pro
Ser Gln Pro Asp
Ser Trp Gly Pro
Ser Trp Pro Gly
Thr Asp Asn Pro
Thr Asp Pro Asn
Thr Asn Asp Pro
Thr Asn Pro Asp
Thr Pro Asp Asn
Thr Pro Asn Asp
Val Cys Pro Gln
Val Cys Gln Pro
Val Pro Cys Gln
Val Pro Gln Cys
Val Gln Cys Pro
Val Gln Pro Cys
Trp Gly Pro Ser
Trp Gly Ser Pro
Trp Pro Gly Ser
Trp Pro Ser Gly
Trp Ser Gly Pro
Trp Ser Pro Gly
PC(6:2/6:2)
3-(5-[(FLUOREN-9-YLMETHOXY)CARBONYLAMINO]PENTYLOXY)BENZOIC ACID
Thiourea, N-[2-(5,6-dimethyl-1H-benzimidazol-2-yl)ethyl]-N-(4-methoxyphenyl)-N-(3-pyridinylmethyl)- (9CI)
Thiourea, N-[2-(5,6-dimethyl-1H-benzimidazol-2-yl)ethyl]-N-(3-methoxyphenyl)-N-(3-pyridinylmethyl)- (9CI)
Thiourea, N-[2-(5,6-dimethyl-1H-benzimidazol-2-yl)ethyl]-N-(2-methoxyphenyl)-N-(3-pyridinylmethyl)- (9CI)
N-(4-Fluorobenzyl)-3-oxo-1,1-diphenyltetrahydro-1H-oxazolo[3,4-a]pyrazine-7(3H)-carboxamide
D000890 - Anti-Infective Agents > D023303 - Oxazolidinones SHA 68 is a potent and selective non-peptide neuropeptide S receptor (NPSR) antagonist with IC50s of 22.0 and 23.8 nM for NPSR Asn107 and NPSR Ile107, respectively. SHA 68 has limited the blood-brain barrier (BBB) penetration and the activity in neuralgia[1][2].
[10,13-dimethyl-17-(1-oxidopyridin-1-ium-3-yl)-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate
6-N-(furan-2-ylmethyl)-4-N-(4-methoxyphenyl)-2-N-[(E)-(4-methoxyphenyl)methylideneamino]-1,3,5-triazine-2,4,6-triamine
1-[2-(5,6-dimethyl-1H-benzimidazol-2-yl)ethyl]-3-(2-methoxyphenyl)-1-(3-pyridinylmethyl)thiourea
(2R,3R,3aS,9bS)-1-[(2,5-difluorophenyl)methyl]-3-(hydroxymethyl)-2-(morpholine-4-carbonyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizin-6-one
(2S,3S,3aR,9bR)-1-[(2,5-difluorophenyl)methyl]-3-(hydroxymethyl)-2-[4-morpholinyl(oxo)methyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizin-6-one
[(2S,3S)-2-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]-6-(3,3,3-trifluoropropyl)-1,6-diazaspiro[3.3]heptan-1-yl]-pyridin-2-ylmethanone
[(2R,3R)-2-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]-6-(3,3,3-trifluoropropyl)-1,6-diazaspiro[3.3]heptan-1-yl]-pyridin-2-ylmethanone
estrone 3-O-(beta-D-glucuronide)(1-)
A steroid glucuronide anion that is the conjugate base of estrone 3-O-(beta-D-glucuronide) arising from deprotonation of the carboxylic acid function; major species at pH 7.3.
Samelisant
Samelisant (SUVN-G3031) is a potent and selective histamine H3 receptor (H3R) inverse agonist with good brain penetration and oral bioavailability. Samelisant has a similar binding affinity towards human (hH3R; Ki=8.7 nM) and rat (rH3R;Ki=9.8 nM) H3R indicating no inter-species differences. Samelisant can be used for the research of sleep-related disorders[1].